Developer docs
API playgroundTry for free, no card

Search company profiles

Thrivable

Full company profile

uuid0002ffm

Namestring
Thrivable
Legal namestring
Thrivable, Inc.
Websiteurl
thrivable.app
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Thrivable, Inc. is a privately held B2B SaaS company headquartered in Bedford Heights, Ohio (Cleveland area), operating a real-time healthcare market research platform that connects pharmaceutical, medical device, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions (diabetes, obesity, and related health conditions). The platform combines a curated patient database with screening and recruitment tools, survey execution capabilities, and an add-on HCP (healthcare professional) research community to deliver patient and provider insights — typically within two weeks — for use cases spanning brand performance evaluation, product adoption analysis, clinical study recruitment, and device strategy refinement. Technology components include patient profile and verification systems, targeted recruitment logic, multi-method survey deployment (online, phone, video focus groups, in-person product testing), and generative AI-assisted content and graphics generation for client deliverables.

The company operates a hybrid revenue model combining enterprise SaaS subscriptions (custom pricing, multi-year Service Orders) with usage-based fees for specific research projects and patient recruitment services, sold through a sales-led enterprise field motion targeting commercial leaders in pharma, medtech, and CROs. Thrivable has reported 700+ projects delivered over seven years of operation with a 75+ Net Promoter Score, and its named customer base includes Medtronic, Tandem Diabetes Care, Diabeloop, American Diabetes Association, Adhera Health, Y-Prime, and Magnolia Innovation. The company has raised approximately $8.1 million in venture funding across rounds in 2019, 2021, and December 2023, with the most recent $6 million Series A led by North Coast Ventures and joined by FCA Venture Partners, Jumpstart Ventures, and Tamarind Hill. Leadership is founder-led by David Edelman (previously founder of Diabetes Daily, acquired by Everyday Health), supported by an executive team covering operations, research, product, marketing, customer success, business development, and finance.

Short descriptiontext

Thrivable is a B2B SaaS healthcare market research platform serving pharma, medtech, and CRO clients with rapid patient insights from a proprietary panel of 120,000+ verified patients across cardiometabolic conditions including diabetes and obesity.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCleveland, United States
HQ citystring
Cleveland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare market research, patient insights platform, patient panel access, pharma market research, cardiometabolic research services
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare Market Research Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Platform Subscription and Research Services
TypeSubscription Recurring
Description

B2B SaaS revenue model providing healthcare companies access to Thrivable's patient insights platform. Companies subscribe to access patient panels, conduct surveys, and receive research findings. Revenue is generated through subscription fees for platform access plus fees for specific research projects and patient recruitment services. The platform enables pharma and medtech companies to rapidly gather patient insights for commercial decisions, product development, and clinical research.

vcaonline.com
2HCP Research Panel Services
TypeProfessional Services
Description

Separate revenue stream from recruiting and engaging healthcare professionals for research studies. HCPs participate in surveys, interviews, and panel discussions about diabetes care, emerging therapies, patient adherence, and treatment decision-making. Compensation to HCPs (up to $500 per activity) is passed through as a service cost to clients.

thrivable.app
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1Enterprise subscription with custom pricing based on research scope and volume
ModelSubscriptionBilling cadenceMulti-year contract
Notes

No public pricing available. B2B SaaS platform requiring direct sales engagement. Pricing determined by usage metrics, project scope, research methodology (qualitative/quantitative), patient recruitment requirements, and deliverables specified in Service Orders.

thrivable.app
2Per-project research services with variable scope
ModelUsage-basedBilling cadencePay-as-you-go
Notes

Pricing varies based on specific project requirements including patient population, study complexity, timeline, and deliverables. Companies pay for research services based on the scope of patient access and insights requested.

vcaonline.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Thrivable is a B2B SaaS healthcare market research platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions. The platform enables rapid patient insights delivery (as little as two weeks) through online surveys, phone surveys, video-based focus groups, and in-person product testing, supported by a separate Healthcare Provider (HCP) research community and patient screening and recruitment tooling.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 700+ projects delivered in diabetes and obesity across pharma and medtech
+3 more records
Product overview1 text field

Thrivable is a B2B SaaS platform providing real-time market research services for healthcare organizations. The core offering is the Thrivable Rapid Research Platform, which connects companies with proprietary patient panels (120,000+ patients) and healthcare professional communities for rapid surveys and user engagement. The platform offers targeted solutions for Pharma Commercial Leaders, MedTech Innovators, and CROs, enabling healthcare teams to gather patient insights in as little as two weeks. The ecosystem includes specialized panels for both patients and healthcare professionals, along with a Findings Friday newsletter for ongoing insights delivery.

Product and service3 records
1Thrivable Rapid Research Platform
CategoryCore platform
Description

A B2B SaaS platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions, enabling online surveys, phone surveys, video-based focus groups, and in-person product testing with insights delivered in as little as two weeks. Targeted at enterprise healthcare commercial leaders, market research professionals, and product/clinical research teams.

2Patient Panel Services
CategoryPatient panel access service
Description

A distinct research service offering access to Thrivable's proprietary database of 120,000+ verified patients across cardiometabolic conditions (diabetes, obesity, and related health conditions) who participate in market research studies on behalf of healthcare companies. Enables rapid recruitment and engagement of targeted patient subsets for research activities.

3HCP Research Community
CategoryHealthcare professional panel
Description

A specialized research community for healthcare professionals (physicians, nurse practitioners, physician assistants, nurses, pharmacists, and allied health professionals with experience in diabetes care and related devices) who participate in surveys, interviews, and panel discussions on diabetes care, emerging therapies, patient adherence, and treatment decision-making. Participants are compensated (up to $500 per activity) with costs passed through to enterprise clients.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthersAnnounced on2021-06-01
Description

Thrivable partners with Tremendous, a rewards and incentive platform, to compensate panel members for participating in research studies. Members earn points or gift cards redeemable through Tremendous, with rewards delivered via email from rewards@reward.tremendous.com. This partnership enables Thrivable to scale member compensation across its 120,000+ patient panel with automated reward fulfillment.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Within3 is a healthcare insights and stakeholder engagement platform serving life sciences companies with HCP and patient communities. Direct comparable on customer base (pharma/medtech), business model (SaaS + services), and use cases (qualitative/quantitative insights). Notable because Thrivable's new VP of BD (Peter Gannon) led global BD at Within3 from 2010-2024.

TypeDirect peer
Description

Sermo operates a global physician community and patient panel used by pharma for market research and HCP engagement. Directly comparable on physician/patient panel model, healthcare market research services, and pharma/medtech customer base. Peter Gannon also previously worked at Sermo.

TypeDirect peer
Description

Apollo Intelligence (parent of InCrowd) provides real-time market research to healthcare and life sciences clients through verified HCP and patient panels. Direct comparable on SaaS insights model and life sciences customer base; Thrivable board member Dan Fitzgerald was formerly CEO of Apollo Intelligence.

TypeDirect peer
Description

Evidation operates a large consented health measurement platform with millions of members, providing patient-generated health data and insights to life sciences. Comparable on patient community plus insights offering for pharma, though with a stronger consumer-health and wearable data orientation.

TypeDirect peer
Description

Inspire runs condition-specific patient communities and partners with life sciences on patient insights, real-world evidence, and clinical research recruitment. Comparable on the patient community + life sciences insights model; Thrivable's therapeutic-area specialization mirrors Inspire's vertical approach.

TypeBroad incumbent
Description

Schlesinger Group is a large, established market research data collection company serving consumer and healthcare buyers across qualitative and quantitative methodologies. Comparable as a healthcare market research incumbent with broader service breadth than Thrivable's panel-led SaaS model.

7Ipsos Healthcare
TypeBroad incumbent
Description

Ipsos is a global market research conglomerate with a dedicated healthcare practice covering pharma, biotech, medical devices, and patient outcomes. Comparable on healthcare market research focus, but at vastly larger scale and broader service portfolio including syndicated trackers.

TypeBroad incumbent
Description

M3 operates a global physician panel and market research business serving pharma and healthcare. Comparable as a scaled healthcare insights platform with global reach that Thrivable aspires to compete with for cardiometabolic research spend.

TypeEmerging player
Description

ZoomRx provides pharma sales and marketing intelligence using physician panels and syndicated trackers. Comparable on physician panel-driven insights for pharma commercial teams, with a stronger focus on sales force and messaging analytics versus patient insights.

TypeEmerging player
Description

Clinical Ink provides digital data capture and eCOA/ePRO solutions for clinical trials, with adjacent patient engagement capabilities. Partially comparable through patient data capture for life sciences, but focused on clinical trial outcomes rather than commercial market research.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Thrivable

Healthcare Market Research Softwarethrivable.app

Thrivable is a B2B SaaS healthcare market research platform serving pharma, medtech, and CRO clients with rapid patient insights from a proprietary panel of 120,000+ verified patients across cardiometabolic conditions including diabetes and obesity.

What Thrivable does

Thrivable, Inc. is a privately held B2B SaaS company headquartered in Bedford Heights, Ohio (Cleveland area), operating a real-time healthcare market research platform that connects pharmaceutical, medical device, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions (diabetes, obesity, and related health conditions). The platform combines a curated patient database with screening and recruitment tools, survey execution capabilities, and an add-on HCP (healthcare professional) research community to deliver patient and provider insights — typically within two weeks — for use cases spanning brand performance evaluation, product adoption analysis, clinical study recruitment, and device strategy refinement. Technology components include patient profile and verification systems, targeted recruitment logic, multi-method survey deployment (online, phone, video focus groups, in-person product testing), and generative AI-assisted content and graphics generation for client deliverables.

The company operates a hybrid revenue model combining enterprise SaaS subscriptions (custom pricing, multi-year Service Orders) with usage-based fees for specific research projects and patient recruitment services, sold through a sales-led enterprise field motion targeting commercial leaders in pharma, medtech, and CROs. Thrivable has reported 700+ projects delivered over seven years of operation with a 75+ Net Promoter Score, and its named customer base includes Medtronic, Tandem Diabetes Care, Diabeloop, American Diabetes Association, Adhera Health, Y-Prime, and Magnolia Innovation. The company has raised approximately $8.1 million in venture funding across rounds in 2019, 2021, and December 2023, with the most recent $6 million Series A led by North Coast Ventures and joined by FCA Venture Partners, Jumpstart Ventures, and Tamarind Hill. Leadership is founder-led by David Edelman (previously founder of Diabetes Daily, acquired by Everyday Health), supported by an executive team covering operations, research, product, marketing, customer success, business development, and finance.

Thrivable firmographics

Firmographics
Name
Thrivable
Legal name
Thrivable, Inc.
Website
https://thrivable.app
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Thrivable is a B2B SaaS healthcare market research platform serving pharma, medtech, and CRO clients with rapid patient insights from a proprietary panel of 120,000+ verified patients across cardiometabolic conditions including diabetes and obesity.
Ownership category
akta.pro rank

Where Thrivable is headquartered

Location

Headquarters

HQ city
Cleveland
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Thrivable business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Platform Subscription and Research Services: B2B SaaS revenue model providing healthcare companies access to Thrivable's patient insights platform. Companies subscribe to access patient panels, conduct surveys, and receive research findings. Revenue is generated through subscription fees for platform access plus fees for specific research projects and patient recruitment services. The platform enables pharma and medtech companies to rapidly gather patient insights for commercial decisions, product development, and clinical research.
  2. HCP Research Panel Services: Separate revenue stream from recruiting and engaging healthcare professionals for research studies. HCPs participate in surveys, interviews, and panel discussions about diabetes care, emerging therapies, patient adherence, and treatment decision-making. Compensation to HCPs (up to $500 per activity) is passed through as a service cost to clients.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise subscription with custom pricing based on research scope and volume
Usage-basedPay-as-you-goPer-project research services with variable scope

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Thrivable product offering

Product offering

Core offering

Thrivable is a B2B SaaS healthcare market research platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions. The platform enables rapid patient insights delivery (as little as two weeks) through online surveys, phone surveys, video-based focus groups, and in-person product testing, supported by a separate Healthcare Provider (HCP) research community and patient screening and recruitment tooling.

Product overview

Thrivable is a B2B SaaS platform providing real-time market research services for healthcare organizations. The core offering is the Thrivable Rapid Research Platform, which connects companies with proprietary patient panels (120,000+ patients) and healthcare professional communities for rapid surveys and user engagement. The platform offers targeted solutions for Pharma Commercial Leaders, MedTech Innovators, and CROs, enabling healthcare teams to gather patient insights in as little as two weeks. The ecosystem includes specialized panels for both patients and healthcare professionals, along with a Findings Friday newsletter for ongoing insights delivery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Thrivable Rapid Research Platform A B2B SaaS platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions, enabling online surveys, phone surveys, video-based focus groups, and in-person product testing with insights delivered in as little as two weeks. Targeted at enterprise healthcare commercial leaders, market research professionals, and product/clinical research teams.
  • Patient Panel Services A distinct research service offering access to Thrivable's proprietary database of 120,000+ verified patients across cardiometabolic conditions (diabetes, obesity, and related health conditions) who participate in market research studies on behalf of healthcare companies. Enables rapid recruitment and engagement of targeted patient subsets for research activities.
  • HCP Research Community A specialized research community for healthcare professionals (physicians, nurse practitioners, physician assistants, nurses, pharmacists, and allied health professionals with experience in diabetes care and related devices) who participate in surveys, interviews, and panel discussions on diabetes care, emerging therapies, patient adherence, and treatment decision-making. Participants are compensated (up to $500 per activity) with costs passed through to enterprise clients.

Quantifiable outcome

  • 700+ projects delivered in diabetes and obesity across pharma and medtech
  • +3 more outcomes

Companies that use Thrivable

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Thrivable technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Thrivable partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TremendouscoreOthers · 1 June 2021Thrivable partners with Tremendous, a rewards and incentive platform, to compensate panel members for participating in research studies. Members earn points or gift cards redeemable through Tremendous, with rewards delivered via email from rewards@reward.tremendous.com. This partnership enables Thrivable to scale member compensation across its 120,000+ patient panel with automated reward fulfillment.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Thrivable competitors and assessment

Company assessment

Direct peers

  • Within3: Within3 is a healthcare insights and stakeholder engagement platform serving life sciences companies with HCP and patient communities. Direct comparable on customer base (pharma/medtech), business model (SaaS + services), and use cases (qualitative/quantitative insights). Notable because Thrivable's new VP of BD (Peter Gannon) led global BD at Within3 from 2010-2024.
  • Sermo: Sermo operates a global physician community and patient panel used by pharma for market research and HCP engagement. Directly comparable on physician/patient panel model, healthcare market research services, and pharma/medtech customer base. Peter Gannon also previously worked at Sermo.
  • InCrowd (now Apollo Intelligence): Apollo Intelligence (parent of InCrowd) provides real-time market research to healthcare and life sciences clients through verified HCP and patient panels. Direct comparable on SaaS insights model and life sciences customer base; Thrivable board member Dan Fitzgerald was formerly CEO of Apollo Intelligence.
  • Evidation Health: Evidation operates a large consented health measurement platform with millions of members, providing patient-generated health data and insights to life sciences. Comparable on patient community plus insights offering for pharma, though with a stronger consumer-health and wearable data orientation.
  • Inspire: Inspire runs condition-specific patient communities and partners with life sciences on patient insights, real-world evidence, and clinical research recruitment. Comparable on the patient community + life sciences insights model; Thrivable's therapeutic-area specialization mirrors Inspire's vertical approach.

Broad incumbents

  • Schlesinger Group: Schlesinger Group is a large, established market research data collection company serving consumer and healthcare buyers across qualitative and quantitative methodologies. Comparable as a healthcare market research incumbent with broader service breadth than Thrivable's panel-led SaaS model.
  • Ipsos Healthcare: Ipsos is a global market research conglomerate with a dedicated healthcare practice covering pharma, biotech, medical devices, and patient outcomes. Comparable on healthcare market research focus, but at vastly larger scale and broader service portfolio including syndicated trackers.
  • M3 (MDLinx / M3 Global Research): M3 operates a global physician panel and market research business serving pharma and healthcare. Comparable as a scaled healthcare insights platform with global reach that Thrivable aspires to compete with for cardiometabolic research spend.

Emerging players

  • ZoomRx: ZoomRx provides pharma sales and marketing intelligence using physician panels and syndicated trackers. Comparable on physician panel-driven insights for pharma commercial teams, with a stronger focus on sales force and messaging analytics versus patient insights.
  • Clinical Ink: Clinical Ink provides digital data capture and eCOA/ePRO solutions for clinical trials, with adjacent patient engagement capabilities. Partially comparable through patient data capture for life sciences, but focused on clinical trial outcomes rather than commercial market research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Thrivable social profiles

Digital presence

Thrivable compliance and trust

Trust signal

Compliance1 record

Thrivable financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Thrivable leadership team

Management profile

Number of profiles

Profiles8 records

Thrivable funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Thrivable M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Thrivable

What does Thrivable do?

Thrivable is a B2B SaaS healthcare market research platform that connects pharmaceutical, medtech, and contract research organization (CRO) clients with a proprietary panel of 120,000+ verified patients across cardiometabolic conditions. The platform enables rapid patient insights delivery (as little as two weeks) through online surveys, phone surveys, video-based focus groups, and in-person product testing, supported by a separate Healthcare Provider (HCP) research community and patient screening and recruitment tooling.

Is Thrivable a public or private company?

Thrivable is a private company. It is classified as venture growth investor backed and is currently operating.

When was Thrivable founded?

Thrivable was founded in 2017. It employs 11 to 50 people.

Where is Thrivable based?

Thrivable is headquartered in Cleveland, United States, in the North America region.

How does Thrivable make money?

Two revenue lines are on record. Platform Subscription and Research Services are the primary driver. The others are HCP Research Panel Services.

Who are Thrivable's main competitors?

Direct peers on record are Within3, Sermo, InCrowd (now Apollo Intelligence), Evidation Health and Inspire. Broad incumbents are Schlesinger Group, Ipsos Healthcare and M3 (MDLinx / M3 Global Research). Emerging players are ZoomRx and Clinical Ink.

Does Thrivable have an API?

No public API is recorded for Thrivable.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooModular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin DeliveryModular Medical completed a three-phase study with Thrivable involving over 540 diabetes participants to assess attitudes toward its Pivot tubeless patch pump. Nine out of 10 multiple daily injection users said they would consider a simpler insulin delivery option, and 82.8% of high-burden participants would discuss Pivot with their provider. The company plans to use these insights for patient engagement and commercialization planning.Stock TitanModular Medical study: ~90% consider simpler pumpsModular Medical completed a market research study with Thrivable of over 540 diabetes participants, finding that about 90% of multiple daily injection users would consider a simpler insulin delivery option. Lower cost and reduced effort were the top motivators, and 82.8% of highly burdened patients said they would discuss Pivot with their provider.ThrivableThrivable Raises $6 Million to Lead the Patient Experience Data RevolutionThrivable has raised $6 million in funding led by North Coast Ventures to enhance its capabilities in capturing patient insights for healthcare organizations. The funding will support Thrivable's expansion of its data monitoring capabilities and comprehensive database, indicating the significant growth potential of the patient experience data market, currently valued at $10 billion in the United States.Spectrum NewsStartup simplifies artificial intelligence for small businessesCleveland-based Pandata provides AI tools and data scientists to small businesses, including Thrivable, a healthcare research platform. The company has worked with about 50 companies, offering access to expensive technology at a fraction of the cost.HealthlineDiabetes: Symptoms, Causes, Treatment, Prevention, and MoreDiabetes mellitus is a metabolic disease where the body doesn't make or use insulin effectively, leading to high blood sugar. Type 2 diabetes affects 90-95% of cases, while type 1 is autoimmune, and gestational diabetes occurs during pregnancy. Management includes blood sugar monitoring, diet, exercise, and insulin when needed.FinSMEsThrivable Raises $1.7M in FundingThrivable, a Cleveland-based real-time market research platform, closed a $1.7 million funding round backed by Allos Ventures, JumpStart, North Coast Ventures, and Early Light Ventures. The company plans to utilize the capital to expand its global workforce in technology, data science, sales, and marketing. Thrivable enables healthcare companies to conduct rapid patient engagement studies, serving clients such as Diabeloop and Tandem Diabetes Care.Venture Capital Access OnlineThrivable Raises $1.7M For Real-time Health Care Market ResearchThrivable has announced the closing of $1.7 million in funding to enhance its real-time health care market research platform. The investment will enable Thrivable to expand its global team and improve its services, aimed at making patient insights more accessible for health care companies. Thrivable's platform currently supports over 40,000 patients, allowing for rapid engagement in market research processes.VC News DailyThrivable Raises $1.7M FundingMarket research platform Thrivable announced the closure of a $1.7 million funding round with participation from Allos Ventures, JumpStart, North Coast Ventures, and Early Light Ventures. The Cleveland-based company provides healthcare companies with faster survey, interview, and usability study capabilities compared to industry standards. This funding will support Thrivable's continued growth in the healthcare market research space.PR NewswireThrivable Raises $1.7M For Real-time Health Care Market ResearchThrivable, a real-time health care market research platform, closed $1.7M in funding. The round includes investors Allos Ventures, JumpStart, North Coast Ventures, and Early Light Ventures, and will expand its global team. The company plans to use the funds to grow its technology, research, data science, sales, and marketing teams.AJMCADA Survey Highlights COVID-19’s Impact on Americans With DiabetesA survey of 2,595 Americans with diabetes found 43% delayed routine care, with over half citing fear of exposure. Financial strain affected 9% of care access and 15% of pump/CGM refills. Telehealth use rose to 73% during the pandemic, with 36% planning to continue.